“…Moreover, oxidative enolate heterocoupling has found use in both industrial and academic circles. For instance, Gavai and co-workers from Bristol-Myers Squibb used this method to synthesize a series of anticancer agents such as BMS-906024 ( 29 ) (currently in phase II clinical trials) . The groups of Overman, , Tang, Nicolaou, Yang, and Thomson , have applied this approach to the syntheses of (−)-actinophyllic acid ( 30 ), spirobacillene A ( 31 ), furanocembranoid precursors such as 32 , (+)-propindilactone G ( 33 ), and metacycloprodigiosin ( 34 ), and propolisbenzofuran B ( 35 ), respectively.…”